Surveillance testing for metastasis from primary uveal melanoma and effect on patient survival

American Journal of Ophthalmology

Volumn 152, Issue 1, 2011, Pages 5-9.e1

  Augsburger, James J ^a   Corrêa, Zélia M ^a,b   Trichopoulos, Nikolaos ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Stetson Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER SCREENING; CANCER SURVIVAL; CHOROID MELANOMA; CILIARY BODY MELANOMA; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL PRACTICE; DISEASE MARKER; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IRIS DISEASE; IRIS MELANOMA; MEDLINE; METASTASIS; OVERALL SURVIVAL; PEER REVIEW; PREDICTIVE VALUE; PRIMARY TUMOR; PRIMARY UVEAL MELANOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SURVIVAL TIME; SYSTEMATIC REVIEW; UVEA DISEASE; UVEA MELANOMA;

EID: 79959592222     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2011.03.004     Document Type: Article

References (40)

1. J.J. Augsburger, Z.M. Corrêa, and A.H. Shaikh Effectiveness of treatments for metastatic uveal melanoma Am J Ophthalmol 148 1 2009 119 127
2. Y. Shildkrot, and M.W. Wilson Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease Curr Opin Ophthalmol 20 6 2009 504 510
3. D. Atkins, P.A. Briss, and M. Eccles Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system BMC Health Serv Res 5 1 2005 25
4. V. Barak, S. Frenkel, and I. Kalickman Serum markers to detect metastatic uveal melanoma Anticancer Res 27 4A 2007 1897 1900 (Pubitemid 46954694)
5. I. Boldin, G. Langmann, and E. Richtig Five-year results of prognostic value of tyrosinase in peripheral blood of uveal melanoma patients Melanoma Res 15 6 2005 503 507 (Pubitemid 44124261)
6. S.A. Callejo, E. Antecka, and P.L. Blanco Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma A prospective longitudinal study Eye (Lond) 21 6 2007 752 759 (Pubitemid 46909176)
7. M. Diener-West, S.M. Reynolds, and D.J. Agugliaro Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23 J Clin Oncol 22 12 2004 2438 2444 (Pubitemid 41115402)
8. M. Diener-West, S.M. Reynolds, and D.J. Agugliaro Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26 Arch Ophthalmol 123 12 2005 1639 1643 (Pubitemid 41785095)
9. L.A. Donoso, R.M. Nagy, and R.J. Brockman Metastatic uveal melanoma Hepatic cell-surface enzymes, isoenzymes, and serum sialic acid levels in early metastatic disease Arch Ophthalmol 101 5 1983 791 794 (Pubitemid 13133118)
10. S. Eskelin, and T. Kivela Imaging to detect metastases from malignant uveal melanoma Arch Ophthalmol 120 5 2002 676 (Pubitemid 34496636)
11. S. Eskelin, S. Pyrhonen, and M. Hahka-Kemppinen A prognostic model and staging for metastatic uveal melanoma Cancer 97 2 2003 465 475 (Pubitemid 36133814)
12. S. Eskelin, S. Pyrhonen, and P. Summanen Screening for metastatic malignant melanoma of the uvea revisited Cancer 85 5 1999 1151 1159 (Pubitemid 29115596)
13. B.F. Fernandes, E. Antecka, G. dos Passos, and M.N. Burnier Jr [Detection of circulating malignant cells in patients with uveal melanoma] Arq Bras Oftalmol 70 4 2007 593 598
14. A.B. Francken, M.J. Fulham, M.J. Millward, and J.F. Thompson Detection of metastatic disease in patients with uveal melanoma using positron emission tomography Eur J Surg Oncol 32 7 2006 780 784 (Pubitemid 44276011)
15. D.S. Gombos, K.R. Van Quill, M. Uusitalo, and J.M. O'Brien Geographic disparities in diagnostic screening for metastatic uveal melanoma Ophthalmology 111 12 2004 2254 2258 (Pubitemid 39575596)
16. E.S. Gragoudas, K.M. Egan, and J.M. Seddon Survival of patients with metastases from uveal melanoma Ophthalmology 98 3 1991 383 389
17. I. Haritoglou, A. Wolf, and T. Maier Osteopontin and 'melanoma inhibitory activity': comparison of two serological tumor markers in metastatic uveal melanoma patients Ophthalmologica 223 4 2009 239 243
18. C. Hicks, A.J. Foss, and J.L. Hungerford Predictive power of screening tests for metastasis in uveal melanoma Eye (Lond) 12 Pt 6 1998 945 948 (Pubitemid 29027034)
19. S.S. Kadkol, A.Y. Lin, and V. Barak Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study Invest Ophthalmol Vis Sci 47 3 2006 802 806 (Pubitemid 46768309)
20. I. Kaiserman, R. Amer, and J. Pe'er Liver function tests in metastatic uveal melanoma Am J Ophthalmol 137 2 2004 236 243 (Pubitemid 38220994)
21. U. Keilholz, P. Goldin-Lang, and N.E. Bechrakis Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reaction Clin Cancer Res 10 5 2004 1605 1612 (Pubitemid 38435549)
22. L. Kodjikian, J.D. Grange, and S. Baldo Prognostic factors of liver metastases from uveal melanoma Graefes Arch Clin Exp Ophthalmol 243 10 2005 985 993 (Pubitemid 41631038)
23. T. Maeda, U. Tateishi, and S. Suzuki Magnetic resonance screening trial for hepatic metastasis in patients with locally controlled choroidal melanoma Jpn J Clin Oncol 37 4 2007 282 286 (Pubitemid 47090680)
24. G.S. Missotten, C.M. Korse, and C. van Dehn S-100B protein and melanoma inhibitory activity protein in uveal melanoma screening A comparison with liver function tests Tumour Biol 28 2 2007 63 69 (Pubitemid 46328593)
25. I.W. Reiniger, U.C. Schaller, and C. Haritoglou "Melanoma inhibitory activity" (MIA): a promising serological tumour marker in metastatic uveal melanoma Graefes Arch Clin Exp Ophthalmol 243 11 2005 1161 1166 (Pubitemid 43124169)
26. I.W. Reiniger, A. Wolf, and U. Welge-Lussen Osteopontin as a serologic marker for metastatic uveal melanoma: results of a pilot study Am J Ophthalmol 143 4 2007 705 707 (Pubitemid 46452513)
27. P. Rietschel, K.S. Panageas, and C. Hanlon Variates of survival in metastatic uveal melanoma J Clin Oncol 23 31 2005 8076 8080 (Pubitemid 46657410)
28. U.C. Schaller, A.K. Bosserhoff, and A.S. Neubauer Melanoma inhibitory activity: a novel serum marker for uveal melanoma Melanoma Res 12 6 2002 593 599 (Pubitemid 36042746)
29. U.C. Schaller, A.J. Mueller, and A.K. Bosserhoff Melanoma inhibitory activity (MIA) Evaluation of a new tumor-associated antigen as a serum marker for uveal melanomas Ophthalmologe 97 6 2000 429 432 (Pubitemid 30435529)
30. R. Schuster, N.E. Bechrakis, and A. Stroux Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma Clin Cancer Res 13 4 2007 1171 1178 (Pubitemid 46424057)
31. I. Sillaire-Houtmann, J. Bonafous, and A. Veyre [Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma] J Fr Ophtalmol 27 1 2004 34 39 (Pubitemid 38176184)
32. D. Suesskind, A. Ulmer, and U. Schiebel Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study Acta Ophthalmol 89 1 2011 17 24
33. K. Tobal, L.S. Sherman, A.J. Foss, and S.L. Lightman Detection of melanocytes from uveal melanoma in peripheral blood using the polymerase chain reaction Invest Ophthalmol Vis Sci 34 9 1993 2622 2625 (Pubitemid 23232469)
34. A. Ulmer, J. Beutel, and D. Susskind Visualization of circulating melanoma cells in peripheral blood of patients with primary uveal melanoma Clin Cancer Res 14 14 2008 4469 4474
35. J.J. Augsburger, and J.W. Gamel Clinical prognostic factors in patients with posterior uveal malignant melanoma Cancer 66 7 1990 1596 1600 (Pubitemid 20355431)
36. J.J. Augsburger, J.W. Gamel, and J.A. Shields Cobalt plaque radiotherapy versus enucleation for posterior uveal melanoma: comparison of survival by prognostic index groups Trans Am Ophthalmol Soc 87 1989 348 359
37. C.L. Loprinzi Follow-up testing for curatively treated cancer survivors What to do? JAMA 273 1995 1877 1878
38. J. Elston Lafata, J. Simpkins, and L. Schultz Routine surveillance care after cancer treatment with curative intent Med Care 43 2005 592 599 (Pubitemid 40847296)
39. L.A. Worley, M.D. Onken, and E. Person Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma Clin Can Res 13 5 2007 1466 1471 (Pubitemid 46450436)
40. B. Damato, and S.E. Coupland Translating uveal melanoma cytogenetics into clinical care Arch Ophthalmol 127 4 2009 423 429